Clinical Trial: A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07705308) titled 'A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma' on July 06.

Brief Summary: Multi center, randomized, controlled, prospective clinical trial to explore the clinical efficacy and safety of low-dose radiotherapy combined with targeted therapy for localized MALT lymphoma.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)

Intervention: RADIATION: Radiation (Very low dose)

4 Gy in 2 consecutive daily fractions subsequently with orelabrutin...